Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 6
2002 4
2003 5
2004 1
2006 2
2007 5
2008 2
2009 3
2010 6
2011 8
2012 2
2013 2
2014 8
2015 7
2016 3
2017 4
2018 4
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
Kawagishi N, et al. PLoS One 2018. PMID 30576386 Free PMC article.
Mean small-dense LDL-C (sdLDL-C), which has greater atherogenic potential, was significantly elevated only in patients with both dyslipidemia (LDL-C >140 mg/dL) and liver steatosis (CAP >248 dB/m) at SVR24. ...However, elevated LDL-C was accompanied with elevated sdLDL-C only in patients with liver steatosis and dyslipidemia at SVR24; therefore, those patients may require closer monitoring....
Mean small-dense LDL-C (sdLDL-C), which has greater atherogenic potential, was significantly elevated only in patients with both dyslipid
Changes in Lipid Indices in HIV+ Cases on HAART
Ji S, et al. Biomed Res Int 2019. PMID 30868068 Free PMC article.
These findings suggest that there are changes in the lipid levels of patients undergoing HAART, with the potential risk of dyslipidemia....
These findings suggest that there are changes in the lipid levels of patients undergoing HAART, with the potential risk of dyslipidemia
Metabolic alterations and hepatitis C: From bench to bedside
Chang ML. World J Gastroenterol 2016 - Review. PMID 26819514 Free PMC article.
Although several lines of transgenic mice expressing core or full HCV proteins exhibit hepatic steatosis and/or dyslipidemia, whether they completely reflect the metabolic alterations in humans with HCV infection remains unknown. ...
Although several lines of transgenic mice expressing core or full HCV proteins exhibit hepatic steatosis and/or dyslipidemia, whether …
Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.
Li J, et al. Int J STD AIDS 2018. PMID 29471762
The main objective of this study was to examine whether cocaine use may modify PI-associated dyslipidemia in adults. Between June 2003 and June 2014, 957 human immunodeficiency virus (HIV)-infected participants in Baltimore, Maryland were enrolled in a study that investigated HIV/antiretroviral therapy-associated comorbidities. ...Our findings showed that long-term cocaine use may exacerbate adverse effects of PI therapy on lipid metabolism, suggesting that reduced cocaine use may be considered an alternative approach to managing PI-associated dyslipidemia in chronic cocaine users with HIV infection....
The main objective of this study was to examine whether cocaine use may modify PI-associated dyslipidemia in adults. Between June 200 …
Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy
Haser GC and Sumpio B. J Vasc Surg 2017 - Review. PMID 26994951 Free article.
OBJECTIVE: Patients infected with human immunodeficiency virus (HIV) have higher rates of dyslipidemia, atherosclerosis, and chronic inflammation that can damage the vascular system compared with the general population. ...The metabolic changes and cell damage induced by HIV and HAART put HIV patients at increased risk for atherosclerosis, dyslipidemia, and serious cardiovascular events such as myocardial infarction and stroke. ...
OBJECTIVE: Patients infected with human immunodeficiency virus (HIV) have higher rates of dyslipidemia, atherosclerosis, and chronic …
Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
Soh H, et al. Gut Liver 2019. PMID 30602222 Free PMC article.
BACKGROUND/AIMS: The risk of herpes zoster (HZ) among patients with inflammatory bowel disease (IBD) remains unclear in terms of age and metabolic comorbidities, including diabetes mellitus, hypertension, or dyslipidemia. ...
BACKGROUND/AIMS: The risk of herpes zoster (HZ) among patients with inflammatory bowel disease (IBD) remains unclear in terms of age and met …
68 results
Jump to page
Feedback